Response to Letter to the Editor Regarding the Immunogenicity of Enhanced Influenza Vaccines in Inducing Neuraminidase Inhibition Antibodies - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reply to Editorial Correspondence on the Immunogenicity of Advanced Influenza Vaccines and Their Role in Neuraminidase Inhibition Antibody Production

  • By

  • Pavithra Daulagala

  • Benjamin J Cowling

  • Hui-Ling Yen

  • January 24, 2026

Share

Original Source(s)

Response to Letter to the Editor Regarding the Immunogenicity of Enhanced Influenza Vaccines in Inducing Neuraminidase Inhibition Antibodies

  • by Pavithra Daulagala, Benjamin J Cowling, Hui-Ling Yen

  • January 24, 2026

Related Content

Top 10 evidence-based essentials in infectious disease

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

Procalcitonin—An Enigmatic Anxiolytic Biomarker

Dynamics of neutralizing antibodies against enterovirus D68 in adults during the COVID-19 pandemic